ProShares Ultra Nasdaq Biotechnology (BIB)

ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund in the Trading Leveraged Equity category. It has $101.35M in assets, an expense ratio of 0.95% and a 0.28% dividend yield. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.